Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
10.25
-0.05 (-0.49%)
May 1, 2025, 12:01 PM EDT - Market open
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $544.17 million as of May 1, 2025. Its market cap has decreased by -29.76% in one year.
Market Cap
544.17M
Enterprise Value
211.61M
1-Year Change
-29.76%
Ranking
Category
Stock Price
$10.25
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has decreased from $654.64M to $544.17M, a decrease of -16.87%. That is a compound annual growth rate of -4.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2025 | 546.83M | -25.21% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 807.25B |
| Johnson & Johnson | 376.09B |
| UnitedHealth Group | 374.50B |
| AbbVie | 345.13B |
| Novo Nordisk | 293.18B |
| Abbott Laboratories | 226.76B |
| Novartis AG | 223.05B |
| AstraZeneca | 221.80B |